Skip to main content
Clinical Trials/NCT04473092
NCT04473092
Completed
Not Applicable

Prospective Analysis of the Feasibility of the PASCAL Spacer Technology for Transcatheter Mitral Valve Repair in an All-comers Cohort

University Hospital, Essen1 site in 1 country80 target enrollmentJuly 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitral Regurgitation
Sponsor
University Hospital, Essen
Enrollment
80
Locations
1
Primary Endpoint
Morphologic and functional changes of mitral valve anatomy
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To identify changes on mitral valve morphology and functionality by the application of the PascalTM in MR.

Detailed Description

Transcatheter mitral valve repair (TMVR) in mitral regurgitation (MR) is increasingly applied in patients on high surgical risk. Interventional mitral valve repair can be applied is routinely applied in primary and secondary mitral regurgitation. While the edge-to-edge technique has been the solely available technlology in the marked for the last years, the recently introduced PascalTM technology represents a novel concept and is characterized by a central spacer, wider paddles, and larger dimensions. Implications of implantation of the PascalTM device on the mitral valve morphology and functionality concerning potential changes on mitral regurgitation as well as changes on mitral valve orifice area are to date not fully understood. The current study will identify anatomical changes to optimize ideal patient selection and optimal treatment approaches of the PASCALTM device.

Registry
clinicaltrials.gov
Start Date
July 20, 2020
End Date
September 30, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Essen
Responsible Party
Principal Investigator
Principal Investigator

Peter Lüdike

Prof. Dr.

University Hospital, Essen

Eligibility Criteria

Inclusion Criteria

  • All patients who undergo TVMR for MR (age \>18yrs) at the PI´s site

Exclusion Criteria

  • Subject does not provide full consent

Outcomes

Primary Outcomes

Morphologic and functional changes of mitral valve anatomy

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials